You are on page 1of 3

DAFTAR PUSTAKA

1.

McPhee SJ and, Ganong WF. Patofisiologi penyakit, Edisi 5. Jakarta; EGC. 2010. Howard IM. The prevention of foot ulceration in diabetic patients. Phys Med Rehabil Clin N Am 2009;20(4):9-609.

2.

3.

Khallaf A-N, Fathi O, Ayad W, Fawzy A. Diabetic foot ulcers: concervative management as limb salvage. Egypt, J. Plast. Reconstr. Surgery 2006;30(2):107-111. Frykberg RG, Zgonis T, Amstrong DG, et al. Diabetic foot disorders. A Clinical Practice Guideline (2006 revision). J Foot Ankle Surg 2006;45(5 Suppl):S1-66. International Diabetes Federation. The global burden. Dalam: Nigel U, Eds. Diabetes atlas. 5th ed. Brussels: IDF; 2012. Reiber GE and Ledoux WR. Epidemiology of diabetic foot ulcers and amputations: evidence for prevention. In: Williams R, Editors. The Evidence Base for Diabetes Care. Washington: John Wiley & Sons; 2003. Reilly M, Mohler E. Cilostazol: treatment of intermittent claudication. Ann Pharmacother 2001;35:48-56. Nakamura N, Hamazaki T, Johkaji H, et al. Effects of cilostazol on serum lipid concentrations and plasma fatty acid composition in type 2 diabetic patients with weripheral vascular disease. Clin Exp Med 2003;2(4):180-4. Ahn CW, Lee HC, Park SW, et al. Decrease in carotid intima media thickness after 1 year of cilostazol treatment in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 2001;52(1):45-53.

4.

5.

6.

7.

8.

9.

10. Miller MS. Pharmacotherapy as adjunctive treatment for serious foot wounds in the patient with diabetes: a case study. Ostomy Wound Manage 2003;49(4):52-5. 11. Mahameed AA. Peripheral arterial disease. Cleveland Clinic publications: Disease Management Project 2009; (online), (http://www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/car diology/peripheral-arterial-disease/, diakses 21 Juni 2013).

12. Layton M, Goodfield MJD, Ibbotson S, et al. Randomised trial of oral aspirin for chronic venous leg ulcers. TheLancet.com 1994; (online), 344: 164-165, (http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(94)927596/abstract, diakses 21 Juni 2013). 13. Abougalambou SSI, Hassali MA, Sulaiman SAS, et al. Prevalence of vascular complications among type 2 diabetes mellitus outpatients at teaching hospital in Malaysia. J DiabeteMetab 2011; 2(1): 1-4. 14. Akhter JM, Khan IA, Shahpurkar VV, et al. Evaluation of the diabetic foot according to Wagner's classification in a rural teaching hospital. The British Journal of Diabetes and Vascular Disease 2011; 11: 74-79. 15. Steeper R. A Critical Review of the Aetiology of Diabetic neuropathic ulcers. J Wound Care 2005;14(3): 101-3. 16. Omi H, Okayama N, Shimizu M, Fuktomi T, Nakamura A, Imaeda K, et al. Cilostazol inhibist high glucose-mediated endothelial-neutrophil adhesion by decreasing adhesion molecule expression via NO production. Microvas Res 2004;68(2):119-25. 17. Ohba R, Otaka M, Odashima M, Jin M, Komatsu K, Konishi N, et al. Effect of cilostazol, a selective type-III phosphodiesterase inhibitor, on waterimmersion stress-induced gastric mucosal injury in rats. J Gastroenterol 2006;41(1): 34-40. 18. Kumar V, Cotran RS, Robbins SL. Buku ajar patologi. Edisi 7 Volume 1. Jakarta, EGC: 2011. 19. Mackay D, Miller AL. Nutritional support for wound healing. Alternative Medicine Review 2003;4(8): 359-377. 20. Diegelmann RF, Evans MC. Wound healing: an overview of acute, fibrotic and delayed healing. Frontiers in Bioscience 2004;9: 283-289. 21. Thompson PD, Zimet R, Forbes WP, et al. Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication. American Journal of Cardiology 2002; 90(12): 1314-1319. 22. Katzung, B.G. Basic and clinical pharmacology. 9th edition. USA : Mc Graw Hill;2005. 23. Keast DH, Bowering CK, Evans AW, et al. Measure: a proposed assessment. Wound Repair Regen 2004;1293:S1-17.

24. Guo S, DiPietro LA. Factors affecting wound healing. J Dent Res 2010; 89(3): 219-229. 25. Rathur H, Rajbhandari. Review prevention of diabetic foot ulcers: holy grail of out clinics. Int J Diabetes & Metabolism 2003; 11: 56-61. 26. Greenhagen RM, Johnson AR, Bevilacque NJ. Smoking cessation: the role of the foot and ankle surgeon. Foot ankle Spec 2010; 3(1): 21-8. 27. Herman H. Efektivitas Cilostazol dan plasebo sebagai ajuvan kaki diabetik Wagner II dan III di RSUD Hasan Sadikin. Tesis. Bandung: Fakultas Kedokteran Universitas Padjajaran Bandung, 2012. 28. Hutagalung HS. Efek aspirin, cilostazol serta clopidogrel terhadap outcome fungsional pada pasien stroke iskemik. Tesis. Medan: Fakultas Kedokteran Universitas Sumatera Utara, 2011.